Figure 5
Figure 5. Inferior outcome for EVI1+ME− patients in comparison with EVI1+ME+ patients. Kaplan Meier analysis of (A) overall survival (OS) and (B) event-free survival (EFS) shows an inferior outcome for EVI1+ME− patients in comparison with EVI1+ME+ patients in the cohort of 41 EVI1+ AML patients.

Inferior outcome for EVI1+ME patients in comparison with EVI1+ME+patients. Kaplan Meier analysis of (A) overall survival (OS) and (B) event-free survival (EFS) shows an inferior outcome for EVI1+ME patients in comparison with EVI1+ME+ patients in the cohort of 41 EVI1+ AML patients.

Close Modal

or Create an Account

Close Modal
Close Modal